| 摘要 |
The present invention relates to an apoptosis inducer composition for hormone-sensitive prostatic cancer cells and a pharmaceutical composition for the prevention or the treatment of the cancer. More particularly, the present invention relates to an apoptosis inducer composition for hormone-sensitive prostatic cancer cells, containing one or more pharmaceutical preparations selected from a group consisting of baicalein, wogonin and gleevec, to an apoptosis inducing method for hormone-sensitive prostatic cancer cells using said composition, to a pharmaceutical composition containing the pharmaceutical preparations for the prevention or the treatment of the hormone-sensitive prostatic cancer, and to a hormone-sensitive prostatic cancer treatment method including the pharmaceutical preparations.
|
| 申请人 |
INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY;KIM, MYEONG OK;MOON, MYEONG HEE;JO, MI JA;KIM, SUNG HOON;PARK, TAE JU |
发明人 |
KIM, MYEONG OK;MOON, MYEONG HEE;JO, MI JA;KIM, SUNG HOON;PARK, TAE JU |
